2002, Volume 09, Issue 06, pages 305-368

Taking vascular disease beyond convention Using the full lipid profile to identify and reduce the risk of coronary heart disease Lipid levels: risks and targets...

An educational intervention was developed to try to raise both data quality standards and those of clinical care in the secondary prevention of coronary heart...

Many general practitioners (GPs) already have a special clinical interest. This role is now being developed and formalised by the Department of Health and by...

Drug interaction with warfarin is a common cause of loss of anticoagulant control. An interaction between warfarin and digoxin has not previously been documented in...

On-call seen as a pathophysiologic state Johan EP Waktare, Alex Stewart, John P Lyons Recently, one of us (AS) underwent 24-hour Holter (ambulatory ECG) monitoring...

Southern Asians in the UK have a substantially increased (50%) risk of coronary heart disease compared with the general population, in part due to a...

This randomised, double-blind, six-month trial assessed the efficacy and tolerability of micronised fenofibrate and pravastatin in 265 patients (18–75 years of age) with primary hyperlipidaemia...

This study assessed complication rates in 64 emergency temporary pacing procedures, of which atrioventricular block formed the largest group (72%). Of the in-hospital deaths, most...

General practitioners (GPs) are subject to bombardments of medical information from many sources – local pharmaceutical formularies, local and national guidelines, national service frameworks, medical...

The onset of symptoms in primary pulmonary hypertension (PPH) is usually insidious with several years elapsing before the diagnosis is actually made. It is important...

Left ventricular hypertrophy (LVH) is more than just an adaptive response to the increase in left ventricular wall stress caused by hypertension. It has long...